Carolina Aguiar Moreira

Carolina Aguiar Moreira

Auto-generated profile, based on publicly available information

Carolina Aguiar Moreira

Universidade Federal do Paraná

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2018 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
HTHeloísa Trierweiler
Heloísa Trierweiler
GKGabrielle Kisielewicz
Gabrielle Kisielewicz
TJThaísa Hoffmann Jonasson
Thaísa Hoffmann Jonasson
RPRicardo Rasmussen Petterle
Ricardo Rasmussen Petterle
CMCarolina Aguiar Moreira
Carolina Aguiar Moreira
VBVictória Zeghbi Cochenski Borba
Victória Zeghbi Cochenski Borba
Diabetics are at increased risk for impaired mobility and strength, frequently related to the disease control. Sarcopenia is the reduction of muscle mass associated with the decrease in muscle strength and/or performance, resulting in worse morbidity in chronic diseases. The objectives of this paper was to assess the prevalence of sarcopenia in patients with type 2 diabetes mellitus (T2DM) and determine its association with diabetes characteristics, progression, and complications, as well as changes in bone mineral density. The sample consisted of patients with T2DM followed at the outpatient clinics of the Serviço de Endocrinologia e Metabologia do Hospital de Clínicas da Universidade Federal do Paraná, from March to August 2016. Participants were men and women above 18 years with T2DM diagnosed at least 1 year earlier. Individuals with chronic diseases, users of any drug that modifies body composition, patients with body mass index (BMI) > 35 or < 18 kg/m2, and users of illicit drugs or hormonal or nutritional supplementation were excluded. The selected patients answered questionnaires about demographics, eating habits, and disease characteristics, and performed a bone densitometry exam in a dual energy absorptiometry (total body; spine and femur (total and neck)), a handgrip test by manual dynamometer, and an evaluation of the abdominal circumference (AC). The medical records were reviewed seeking diabetes data and laboratory test results. Patients were matched for sex, age, and race with healthy controls [Control Group (CG)]. The diagnosis of sarcopenia was conducted according to the criteria of the Foundation for National Institute of Health. The final sample consisted of 83 patients in the DG and 83 in the CG. The DG had higher BMI, WC, past history of fractures and lower calcium and healthy diet intake (p < 0.005), compared to the CG. The DG presented a higher frequency of abnormal BMD (osteopenia in 45 (53%), and osteoporosis in 14 (19%)) and comorbidities than the CG (p < 0.005). Pre-sarcopenia was not different between groups, but muscle weakness was present in 25 diabetics (18 women) and only in 5 controls (4 men) (p = 0.00036). Sarcopenia was diagnosed in 13 (16.2%) patients in the DG and 2 (2.4%) in the CG (p = 0.01168). Pre-sarcopenia and sarcopenia were associated with altered BMD (p < 0.005), with no association with diabetes duration or control. Body mass index and osteoporosis increased the likelihood to have sarcopenia, but hypertension and healthy diet decreased it. The DG had altered BMD associated with worse glycemic control, and a higher prevalence of sarcopenia, suggesting the need to look for their presence in diabetics.

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
GFGhada El-Hajj Fuleihan
Ghada El-Hajj Fuleihan
MCMarlene Chakhtoura
Marlene Chakhtoura
CCCristiana Cipriani
Cristiana Cipriani
RERichard Eastell
Richard Eastell
TKTatiana Karonova
Tatiana Karonova
CMClaudio Marcocci
Claudio Marcocci
This narrative review summarizes data on classical and nonclassical manifestations of primary hyperparathyroidism (PHPT). It is based on a rigorous literature search, inclusive of a Medline search for systematic reviews from 1940 to December 2020, coupled with a targeted search for original publications, covering four databases, from January 2013–December 2020, and relevant articles from authors’ libraries. We present the most recent information, identify knowledge gaps, and suggest a research agenda. The shift in the presentation of PHPT from a predominantly symptomatic to an asymptomatic disease, with its varied manifestations, has presented several challenges. Subclinical nephrolithiasis and vertebral fractures are common in patients with asymptomatic disease. The natural history of asymptomatic PHPT with no end organ damage at diagnosis is unclear. Some observational and cross-sectional studies continue to show associations between PHPT and cardiovascular and neuropsychological abnormalities, among the different disease phenotypes. Their causal relationship is uncertain. Limited new data are available on the natural history of skeletal, renal, cardiovascular, neuropsychological, and neuromuscular manifestations and quality of life. Normocalcemic PHPT (NPHPT) is often diagnosed without the fulfillment of rigorous criteria. Randomized clinical trials have not demonstrated a consistent long-term benefit of parathyroidectomy (PTX) versus observation on nonclassical manifestations. We propose further refining the definition of asymptomatic disease, into two phenotypes: one without and one with evidence of target organ involvement, upon the standard evaluation detailed in our recommendations. Each of these phenotypes can present with or without non-classical manifestations. We propose multiple albumin-adjusted serum calcium determinations (albumin-adjusted and ionized) and exclusion of all secondary causes of high parathyroid hormone (PTH) when establishing the diagnosis of NPHPT. Refining the definition of asymptomatic disease into the phenotypes proposed will afford insights into their natural history and response to interventions. This would also pave the way for the development of evidence-based guidance and recommendations. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

16 November 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
TCTatiana Munhoz da Rocha Lemos Costa
Tatiana Munhoz da Rocha Lemos Costa
VBVictória Zeghbi Cochenski Borba
Victória Zeghbi Cochenski Borba
RCRenata Gonçalves Pinheiro Correa
Renata Gonçalves Pinheiro Correa
CMCarolina Aguiar Moreira
Carolina Aguiar Moreira
Stress fractures (SF) represent 10%-20% of all injuries in sport medicine. An SF occurs when abnormal and repetitive loading is applied on normal bone: The body cannot adapt quickly enough, leading to microdamage and fracture. The etiology is multifactorial with numerous risk factors involved. Diagnosis of SF can be achieved by identifying intrinsic and extrinsic factors, obtaining a good history, performing a physical exam, and ordering laboratory and imaging studies (magnetic resonance imaging is the current gold standard). Relative [...] ABSTRACT Stress fractures (SF) represent 10%-20% of all injuries in sport medicine. An SF occurs when abnormal and repetitive loading is applied on normal bone: The body cannot adapt quickly enough, leading to microdamage and fracture. The etiology is multifactorial with numerous risk factors involved. Diagnosis of SF can be achieved by identifying intrinsic and extrinsic factors, obtaining a good history, performing a physical exam, and ordering laboratory and imaging studies (magnetic resonance imaging is the current gold standard). Relative

1 December 2016 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MLMaicon Piana Lopes
Maicon Piana Lopes
BKBreno S Kliemann
Breno S Kliemann
IBIleana Borsato Bini
Ileana Borsato Bini
RKRodrigo Kulchetscki
Rodrigo Kulchetscki
VBVictor Borsani
Victor Borsani
CMCarolina A Moreira
Carolina A Moreira
Key words: Hypoparathyroidism; renal complication; renal calcification; hypocalcemia; pseudohypoparathyroidism

27 May 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CMCarolina Aguiar Moreira
Carolina Aguiar Moreira
CFCarlos Ferreira
Carlos Ferreira
MMMiguel Madeira
Miguel Madeira
BSBarbara Campolina Carvalho Silva
Barbara Campolina Carvalho Silva
SMSergio Setsuo Maeda
Sergio Setsuo Maeda
MLMarise Lazaretti-Castro
Marise Lazaretti-Castro
Hypovitaminosis D is a common condition with a negative impact on health. This statement, prepared by experts from the Brazilian Society of Endocrinology and Metabolism and the Brazilian Society of Clinical Pathology/Laboratory Medicine, includes methodological aspects and limitations of the measurement of 25-hydroxyvitamin D [25(OH)D] for identification of vitamin D status, and identifies individuals at increased risk for deficiency of this vitamin in whom 25(OH)D measurement is recommended. For the general population, 25(OH)D levels between 20 and 60 ng/mL are considered normal, while individuals with levels below 20 ng/mL are considered to be vitamin D deficient. This statement identifies potential benefits of maintaining 25(OH)D levels > 30 ng/mL in specific conditions, including patients aged > 65 years or pregnant, those with recurrent falls, fragility fractures, osteoporosis, secondary hyperparathyroidism, chronic kidney disease, or cancer, and individuals using drugs with the potential to affect the vitamin D metabolism. This statement also calls attention to the risk of vitamin D intoxication, a life-threatening condition that occurs at 25(OH)D levels above 100 ng/mL

1 June 2020 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
JMJúlia V. Oberger Marques
Júlia V. Oberger Marques
CMCarolina A. Moreira
Carolina A. Moreira